Addyi Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $45.6M

Addyi General Information

Description

Operator of a medical company intended for the treatment of female sexual dysfunction. The company offers a drug that helps in the treatment of acquired extremely low libido, enabling pre-menopausal women to reduce distress from the loss of sexual desire and increase the number of satisfying sexual events.

Contact Information

Website
www.addyi.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4350 Lassiter at North Hills Avenue
  • Suite 260
  • Raleigh, NC 27609
  • United States
+1 (844)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4350 Lassiter at North Hills Avenue
  • Suite 260
  • Raleigh, NC 27609
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Addyi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 23-Dec-2024 $45.6M Completed Generating Revenue
9. Later Stage VC 04-Sep-2019 Completed Generating Revenue
8. Seed Round 04-Jan-2018 Completed Generating Revenue
7. Merger/Acquisition 06-Nov-2017 Completed Generating Revenue
6. Merger/Acquisition 01-Oct-2015 Completed Generating Revenue
5. Seed Round 08-Jun-2015 Completed Generating Revenue
4. Seed Round 11-Jul-2014 Completed Startup
3. Seed Round 26-Jul-2013 Completed Startup
2. Seed Round 11-Jul-2012 $20M $25M Completed Startup
1. Seed Round 21-Mar-2012 $5M $5M Completed Startup
To view Addyi’s complete valuation and funding history, request access »

Addyi Patents

Addyi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026146455-A1 Treatment of sexual desire disorders in patients treated with glp-1 agonists and related agents Pending 03-Jan-2025
EP-2376457-A2 Crystalline salt forms of flibanserine Inactive 15-Dec-2008
CA-2686480-A1 New salts Inactive 15-Dec-2008
US-20120322810-A9 New salts Inactive 15-Dec-2008
US-20150126524-A1 Salts Active 15-Dec-2008 C07D235/26
To view Addyi’s complete patent history, request access »

Addyi Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Addyi Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Auven Therapeutics PE/Buyout Minority
Bausch Health Companies Corporation Majority
Lunsford Capital Venture Capital Minority
Angel (individual) Minority
Scientia Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Addyi FAQs

  • When was Addyi founded?

    Addyi was founded in 2011.

  • Where is Addyi headquartered?

    Addyi is headquartered in Raleigh, NC.

  • What is the size of Addyi?

    Addyi has 31 total employees.

  • What industry is Addyi in?

    Addyi’s primary industry is Pharmaceuticals.

  • Is Addyi a private or public company?

    Addyi is a Private company.

  • What is Addyi’s current revenue?

    The current revenue for Addyi is .

  • How much funding has Addyi raised over time?

    Addyi has raised $70.1M.

  • Who are Addyi’s investors?

    Auven Therapeutics, Bausch Health Companies, Lunsford Capital, , and Scientia Ventures are 5 of 6 investors who have invested in Addyi.

  • When was Addyi acquired?

    Addyi was acquired on 23-Dec-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process